Search

everythinglearnresearchcommunity

for

Search:↓

Men with early onset hair loss are more likely to have high uric acid levels.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Men with male pattern baldness are more likely to have unhealthy blood lipid levels, which could signal other health issues.

Many young men with hair loss have low levels of vitamin D and B12.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Taking 1 mg finasteride for a year reduces dihydrotestosterone levels in men with early hair loss, but doesn't change their metabolic state.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Men with male pattern baldness don't necessarily have high levels of Dehydroepyandrosterone-sulfate, and there's no link between its levels and the severity of hair loss.

Growth factors greatly affect hair loss, with different levels seen in men, women, younger patients, and at the start of the condition.

Men with hair loss may lack zinc, copper, and vitamin D; supplements could help.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Platelet-rich plasma injections significantly improve hair density and thickness in both male and female pattern hair loss, especially in early stages.

Hair loss in Chinese college students leads to various psychological issues, so treatment should address both hair loss and mental health.

Finasteride helps hair growth but may cause sexual side effects and depression.

Platelet rich plasma therapy significantly improves hair growth and increases the number of hair follicles in men with androgenetic alopecia.

PRP treatment can increase hair growth in male pattern baldness, but this effect is not linked to the levels of growth factors or the number of platelets.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Vitamin D is linked to hair health, but more research is needed for its use in treating female hair loss.

Psoriasis, acne, and hair loss are linked to unhealthy cholesterol levels, increasing heart disease risk.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.

Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.

Too much androgen can cause hair loss; finasteride may help.

Testosterone treatment in trans men increases body and facial hair and may lead to hair loss over time, but severe skin issues are rare.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Using a special stem cell formula on the scalp once a month for six months helped people with hair loss grow more hair.

There is no significant link between male pattern baldness and insulin resistance.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Men with balding at age 45 had higher IGF-1 and lower IGFBP-3, suggesting these factors might be important in male pattern baldness.